Company page

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. (KPTI) is a public company based in the United States, focusing on the development of innovative therapies for cancer and other serious diseases. With a market capitalization of approximately $204.4 million, Karyopharm is dedicated to advancing its pipeline of treatments aimed at improving patient outcomes. The company is committed to addressing unmet medical needs through its research and development efforts.